secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001005286-24-000050
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore receives Nasdaq notice for delayed Q3 10-Q; hearing held April 16, decision pending
--------------------------------------------------------------------------------

- Nasdaq notice on April 15, 2024, cites continued non-compliance with Listing Rule 5250(c)(1) due to late Q3 10-Q and prior Q1/Q2 filings.
- Company appealed prior Staff Delisting Determination; hearing held April 16, 2024, requesting further stay of suspension/delisting.
- Nasdaq Hearings Panel has not yet issued a decision; no immediate effect on LFCR stock trading.
- Company intends to file overdue reports as promptly as possible but gives no assurance of timeline or panel grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000050/0001005286-24-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000050/lndc-20240415.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer